ZA202403104B - Pharmaceutical formulation comprising tacrolimus, method for the preparation thereof and use - Google Patents

Pharmaceutical formulation comprising tacrolimus, method for the preparation thereof and use

Info

Publication number
ZA202403104B
ZA202403104B ZA2024/03104A ZA202403104A ZA202403104B ZA 202403104 B ZA202403104 B ZA 202403104B ZA 2024/03104 A ZA2024/03104 A ZA 2024/03104A ZA 202403104 A ZA202403104 A ZA 202403104A ZA 202403104 B ZA202403104 B ZA 202403104B
Authority
ZA
South Africa
Prior art keywords
tacrolimus
preparation
pharmaceutical formulation
microparticles
relates
Prior art date
Application number
ZA2024/03104A
Other languages
English (en)
Inventor
Evangelos Karavas
Efthymios Koutris
Lida Kalantzi
Sotiria Chaitidou
Nikos Lemonakis
Anna Papadaki
Vincent Brieudes
Artemis Kalezi
Athanasios Katsenis
Katerina Kotti
Original Assignee
Pharmathen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GR20210100639A external-priority patent/GR1010308B/el
Priority claimed from GB2116138.5A external-priority patent/GB2612779A/en
Application filed by Pharmathen Sa filed Critical Pharmathen Sa
Publication of ZA202403104B publication Critical patent/ZA202403104B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2024/03104A 2021-09-27 2024-04-22 Pharmaceutical formulation comprising tacrolimus, method for the preparation thereof and use ZA202403104B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GR20210100639A GR1010308B (el) 2021-09-27 2021-09-27 Φαρμακευτικο σκευασμα που περιλαμβανει τακρολιμους, μεθοδος για την παρασκευη και χρηση αυτου
GB2116138.5A GB2612779A (en) 2021-11-10 2021-11-10 Pharmaceutical formulation comprising Tacrolimus, method for the preparation thereof and use
PCT/EP2022/025445 WO2023046321A1 (en) 2021-09-27 2022-09-27 Pharmaceutical formulation comprising tacrolimus, method for the preparation thereof and use

Publications (1)

Publication Number Publication Date
ZA202403104B true ZA202403104B (en) 2025-01-29

Family

ID=83902713

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2024/03104A ZA202403104B (en) 2021-09-27 2024-04-22 Pharmaceutical formulation comprising tacrolimus, method for the preparation thereof and use

Country Status (10)

Country Link
US (1) US20250319028A1 (cg-RX-API-DMAC7.html)
EP (1) EP4440550A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024536879A (cg-RX-API-DMAC7.html)
KR (1) KR20240060874A (cg-RX-API-DMAC7.html)
AU (1) AU2022351126A1 (cg-RX-API-DMAC7.html)
CA (1) CA3233139A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024005380A2 (cg-RX-API-DMAC7.html)
MX (1) MX2024003886A (cg-RX-API-DMAC7.html)
WO (1) WO2023046321A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202403104B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120000593B (zh) * 2024-12-27 2026-03-20 广东药科大学 一种他克莫司微晶及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080124400A1 (en) 2004-06-24 2008-05-29 Angiotech International Ag Microparticles With High Loadings Of A Bioactive Agent
US20060210638A1 (en) 2005-03-17 2006-09-21 Elan Pharma International Limited Injectable compositions of nanoparticulate immunosuppressive compounds
EP3439654A4 (en) * 2016-04-05 2020-03-18 The Hospital For Sick Children SYSTEM FOR DELIVERING FK506 TO IMPROVE NERVOUS REGENERATION

Also Published As

Publication number Publication date
EP4440550A1 (en) 2024-10-09
AU2022351126A1 (en) 2024-05-09
US20250319028A1 (en) 2025-10-16
CA3233139A1 (en) 2023-03-30
CO2024005380A2 (es) 2024-05-30
JP2024536879A (ja) 2024-10-08
MX2024003886A (es) 2024-07-10
KR20240060874A (ko) 2024-05-08
WO2023046321A8 (en) 2024-05-30
WO2023046321A1 (en) 2023-03-30

Similar Documents

Publication Publication Date Title
NZ607797A (en) Corticosteroids for the treatment of joint pain
EP3753966A4 (en) AMPHIPHILES BLOCK COPOLYMER, MANUFACTURING METHOD FOR THEREFORE AND NANOMICELLAL DRUG LOADING SYSTEM
FI3655017T3 (fi) Farmaseuttinen koostumus
NZ595294A (en) Intraocular sustained release drug delivery systems and methods for treating ocular conditions
EA201401348A1 (ru) Технология приготовления имплантируемой формы палиперидона
MX380923B (es) Micropartículas cargadas con ciclosporina de liberación sostenida.
DE69534163D1 (de) Polymerteilchen zur arzneimittelabgabe
MX2014011815A (es) Composiciones farmaceuticas de liberacion inmediata con propiedades disuasivas de abuso.
ES2721850T3 (es) Nanopartículas poliméricas terapéuticas que comprenden alcaloides vinca y procedimientos de fabricación y uso de las mismas
WO2012054923A3 (en) Therapeutic nanoparticles with high molecular weight copolymers
UA119430C2 (uk) Спосіб приготування лікарської форми рисперидону або паліперидону для імплантування
WO2018183224A3 (en) Injectable and biodegradable polymer formulations for controlled release of bioligic agents
MX392770B (es) Composición farmacéutica de estabilidad mejorada.
WO2013036309A3 (en) Sustained release formulations for delivery of proteins to the eye and methods of preparing same
WO2018208829A8 (en) Biodegradable microparticles for sustained delivery of anti-angiogenic peptide
MX369530B (es) Composiciones de mezclas polimericas absorbibles con velocidades de absorcion controlables de manera precisa, metodos de procesamiento y dispositivos medicos dimensionalmente estables elaborados a partir de estas.
MX2020000377A (es) Esterilizacion mediante radiacion de formas de dosis de polimero hipercomprimido.
PH12013000124A1 (en) Pharmaceutical microsphere for embolization
MX2020006188A (es) Composiciones farmaceuticas que tienen una duracion de liberacion seleccionada.
UY38673A (es) Producto farmacéutico combinado que contiene leuprolido, un polímero biodegradable y gnrh o agonista
HRP20250396T1 (hr) Depo sustavi koji sadrže glatiramer acetat
HK1208383A1 (en) Bioresorbable polymer peripheral scaffolds made from block copolymers of poly(l-lactide) and hydrophilic polymers
EP4374861A3 (en) A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
WO2023046321A8 (en) Pharmaceutical formulation comprising tacrolimus, method for the preparation thereof and use
WO2007130134A3 (en) Controlled release microparticles